299 related articles for article (PubMed ID: 32113923)
1. Independent Validation of Early-Stage Non-Small Cell Lung Cancer Prognostic Scores Incorporating Epigenetic and Transcriptional Biomarkers With Gene-Gene Interactions and Main Effects.
Zhang R; Chen C; Dong X; Shen S; Lai L; He J; You D; Lin L; Zhu Y; Huang H; Chen J; Wei L; Chen X; Li Y; Guo Y; Duan W; Liu L; Su L; Shafer A; Fleischer T; Moksnes Bjaanæs M; Karlsson A; Planck M; Wang R; Staaf J; Helland Å; Esteller M; Wei Y; Chen F; Christiani DC
Chest; 2020 Aug; 158(2):808-819. PubMed ID: 32113923
[TBL] [Abstract][Full Text] [Related]
2. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
3. A prognostic DNA methylation signature for stage I non-small-cell lung cancer.
Sandoval J; Mendez-Gonzalez J; Nadal E; Chen G; Carmona FJ; Sayols S; Moran S; Heyn H; Vizoso M; Gomez A; Sanchez-Cespedes M; Assenov Y; Müller F; Bock C; Taron M; Mora J; Muscarella LA; Liloglou T; Davies M; Pollan M; Pajares MJ; Torre W; Montuenga LM; Brambilla E; Field JK; Roz L; Lo Iacono M; Scagliotti GV; Rosell R; Beer DG; Esteller M
J Clin Oncol; 2013 Nov; 31(32):4140-7. PubMed ID: 24081945
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic modifications in
Wei Y; Liang J; Zhang R; Guo Y; Shen S; Su L; Lin X; Moran S; Helland Å; Bjaanæs MM; Karlsson A; Planck M; Esteller M; Fleischer T; Staaf J; Zhao Y; Chen F; Christiani DC
Clin Epigenetics; 2018; 10():41. PubMed ID: 29619118
[TBL] [Abstract][Full Text] [Related]
5. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
6. LINE-1 hypomethylation is associated to specific clinico-pathological features in Stage I non-small cell lung cancer.
Imperatori A; Sahnane N; Rotolo N; Franzi F; Nardecchia E; Libera L; Romualdi C; Cattoni M; Sessa F; Dominioni L; Furlan D
Lung Cancer; 2017 Jun; 108():83-89. PubMed ID: 28625654
[TBL] [Abstract][Full Text] [Related]
7. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
[TBL] [Abstract][Full Text] [Related]
8. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.
Ooki A; Maleki Z; Tsay JJ; Goparaju C; Brait M; Turaga N; Nam HS; Rom WN; Pass HI; Sidransky D; Guerrero-Preston R; Hoque MO
Clin Cancer Res; 2017 Nov; 23(22):7141-7152. PubMed ID: 28855354
[No Abstract] [Full Text] [Related]
9. EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC.
Zhang R; Lai L; He J; Chen C; You D; Duan W; Dong X; Zhu Y; Lin L; Shen S; Guo Y; Su L; Shafer A; Moran S; Fleischer T; Bjaanæs MM; Karlsson A; Planck M; Staaf J; Helland Å; Esteller M; Wei Y; Chen F; Christiani DC
Epigenetics; 2019 Feb; 14(2):118-129. PubMed ID: 30665327
[TBL] [Abstract][Full Text] [Related]
10. Epigenome-wide gene-age interaction analysis reveals reversed effects of
Chen C; Wei Y; Wei L; Chen J; Chen X; Dong X; He J; Lin L; Zhu Y; Huang H; You D; Lai L; Shen S; Duan W; Su L; Shafer A; Fleischer T; Bjaanæs MM; Karlsson A; Planck M; Wang R; Staaf J; Helland Å; Esteller M; Zhang R; Chen F; Christiani DC
Aging (Albany NY); 2020 Jun; 12(11):10642-10662. PubMed ID: 32511103
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic-smoking interaction reveals histologically heterogeneous effects of TRIM27 DNA methylation on overall survival among early-stage NSCLC patients.
Ji X; Lin L; Shen S; Dong X; Chen C; Li Y; Zhu Y; Huang H; Chen J; Chen X; Wei L; He J; Duan W; Su L; Jiang Y; Fan J; Guan J; You D; Shafer A; Bjaanaes MM; Karlsson A; Planck M; Staaf J; Helland Å; Esteller M; Wei Y; Zhang R; Chen F; Christiani DC
Mol Oncol; 2020 Nov; 14(11):2759-2774. PubMed ID: 33448640
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
Huang YT; Heist RS; Chirieac LR; Lin X; Skaug V; Zienolddiny S; Haugen A; Wu MC; Wang Z; Su L; Asomaning K; Christiani DC
J Clin Oncol; 2009 Jun; 27(16):2660-7. PubMed ID: 19414679
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer.
Navarro A; Moises J; Santasusagna S; Marrades RM; Viñolas N; Castellano JJ; Canals J; Muñoz C; Ramírez J; Molins L; Monzo M
BMC Pulm Med; 2019 Feb; 19(1):55. PubMed ID: 30819158
[TBL] [Abstract][Full Text] [Related]
14. Identification of prognostic signature of non-small cell lung cancer based on TCGA methylation data.
Wang Y; Wang Y; Wang Y; Zhang Y
Sci Rep; 2020 May; 10(1):8575. PubMed ID: 32444802
[TBL] [Abstract][Full Text] [Related]
15. DNA Methylation of
Guo Y; Zhang R; Shen S; Wei Y; Salama SM; Fleischer T; Bjaanæs MM; Karlsson A; Planck M; Su L; Zhu Z; Staaf J; Helland Å; Esteller M; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2018 Dec; 27(12):1527-1535. PubMed ID: 30185536
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer.
Zhang X; Yang X; Wang J; Liang T; Gu Y; Yang D
Int J Clin Exp Pathol; 2015; 8(9):11452-7. PubMed ID: 26617874
[TBL] [Abstract][Full Text] [Related]
17. Deep Learning for Prediction of N2 Metastasis and Survival for Clinical Stage I Non-Small Cell Lung Cancer.
Zhong Y; She Y; Deng J; Chen S; Wang T; Yang M; Ma M; Song Y; Qi H; Wang Y; Shi J; Wu C; Xie D; Chen C;
Radiology; 2022 Jan; 302(1):200-211. PubMed ID: 34698568
[TBL] [Abstract][Full Text] [Related]
18. A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer.
Shen S; Zhang R; Guo Y; Loehrer E; Wei Y; Zhu Y; Yuan Q; Moran S; Fleischer T; Bjaanaes MM; Karlsson A; Planck M; Staaf J; Helland Å; Esteller M; Su L; Chen F; Christiani DC
Mol Oncol; 2018 Jun; 12(6):913-924. PubMed ID: 29656435
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of the p16 and Wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers.
Yoshino M; Suzuki M; Tian L; Moriya Y; Hoshino H; Okamoto T; Yoshida S; Shibuya K; Yoshino I
Int J Oncol; 2009 Nov; 35(5):1201-9. PubMed ID: 19787276
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer.
Malentacchi F; Simi L; Nannelli C; Andreani M; Janni A; Pastorekova S; Orlando C
Lung Cancer; 2009 Jun; 64(3):271-6. PubMed ID: 19022520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]